Last week saw the return of our annual Spring Conference 2021 – and what an event it was! Marking BSAC’s 50th anniversary, the two-day event was our biggest yet, including 15 interactive sessions, 28 poster presentations and 9 exhibitors, all taking place in our custom-built virtual platform...
The audited accounts and trustees report for the period ending 30 September 2020, which are submitted to the AGM, are available to view here.
BSAC is inviting expressions of interest for research on: “Translational research of COVID-19 and its impact on infection management, specifically addressing antimicrobial stewardship”.
BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.
The Officers, Chief Executive, and staff of BSAC are deeply saddened to hear that Sir Paul Cosford, PHE Emeritus Medical Director has died. Sir Paul’s contribution to public health was admirable, considerable and will be greatly missed.
This April, the team from BSAC and JAC are joining a group of fundraisers, including Una Health, Page Medical, as well as a number of other individual fundraisers, to help support our global health initiative, Stop Superbugs.
The British Society for Antimicrobial Chemotherapy (BSAC) welcomes the news that UK Prime Minister Boris Johnson has joined more than 20 international leaders in calling for a settlement that will help the world prepare for future pandemics, and is keen to ensure that, as a ‘slow-motion catastrophe’, antimicrobial resistance (AMR) is now made a top priority on the global health security agenda.
Helping healthcare facilities globally to measure and enhance IPC, data collection / usage and antimicrobial stewardship programmes. Reducing preventable deaths from infections through effective antimicrobial use